Cargando…
Magnesium sulfate and fetal neuroprotection: overview of clinical evidence
Antenatal administration of magnesium sulfate is an important part of the neuroprotective strategy for preterm infants. Strong evidence from five randomized controlled trials and five meta-analyses has demonstrated that magnesium sulfate, when administered before preterm delivery, significantly redu...
Autores principales: | Chollat, Clément, Marret, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199933/ https://www.ncbi.nlm.nih.gov/pubmed/30323118 http://dx.doi.org/10.4103/1673-5374.241441 |
Ejemplares similares
-
Fetal Neuroprotection by Magnesium Sulfate: From Translational Research to Clinical Application
por: Chollat, Clément, et al.
Publicado: (2018) -
Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain
por: Lecuyer, Matthieu, et al.
Publicado: (2017) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
por: Chollat, Clément, et al.
Publicado: (2017) -
Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants
por: Bouet, Pierre-Emmanuel, et al.
Publicado: (2015) -
Effect of Neuroprotective Magnesium Sulfate Treatment on Brain Transcription Response to Hypoxia Ischemia in Neonate Mice
por: Le Dieu-Lugon, Bérénice, et al.
Publicado: (2021)